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ABSTRACT 
Context. Appropriate outcomes are required to evaluate transition programs’ ability to 
maintain care continuity during the transfer to adult care of youths with a chronic condition. 
Objective. To identify the outcomes used to measure care continuity during transfer, and to 
analyze current evidence regarding the efficacy of transition programs.  
Data Sources. Pubmed (1948-2014), Web of Science (1945-2014), EMBASE (1947-2014) 
and the reference lists of the studies identified.  
Study Selection. Screening on titles and abstracts; full-text assessment by two reviewers 
independently. 
Data Extraction. By two reviewers independently, using a Cochrane form adapted to 
observational studies, including bias assessment.  
Results. Among the 23 studies retrieved, all but five were monocentric, 16 were cohorts (15 
retrospective), six cross-sectional studies and one randomized trial. The principal disease 
studied was diabetes (n=11). We identified 24 indicators relating to two main aspects of 
continuity of care: engagement and retention in adult care. As designed, most studies probably 
overestimated engagement. A lack of adjustment for confounding factors was the main 
limitation of the few studies evaluating the efficacy of transition programs. 
Limitations. The assessment of bias was challenging, due to the heterogeneity and 
observational nature of the studies. 
Conclusions. This review highlights the paucity of knowledge about the efficacy of transition 
programs for ensuring care continuity during the transfer from pediatric to adult care. The 
outcomes identified are relevant and not specific to a particular disease. However, the 
prospective follow-up of patients initially recruited in pediatric care should be encouraged to 
limit an overestimation of care continuity. 
  
INTRODUCTION 
In high-income countries, the prognosis of childhood-onset chronic conditions has improved 
in recent decades, such that larger numbers of patients now reach adulthood. For instance, the 
proportion of cystic fibrosis patients reaching adulthood (> 18 years of age) increased from 
27% to 56% between 1982 and 2007 (UK CF Registry, Annual Data Report 2008, Cystic 
Fibrosis Trust 2009) and forecasts indicate an expected increase in the overall number of adult 
cystic fibrosis patients of about 75% by 2025 in Western European countries1. It is estimated 
that almost 90% of children with congenital heart diseases will survive into adulthood2, 
together with 94% of children with sickle cell anemia3. The population of perinatally HIV-
infected patients is also ageing4.  
For several reasons, including the occurrence of adult-specific issues, such as reproduction, 
these patients need to be transferred from pediatric to adult care. However, several studies 
have suggested that this transfer may be associated with poor outcomes including a low 
frequency of medical visits5,6, a lack of compliance with treatment regimens7,8 and a higher 
risk of unplanned healthcare use9,10. It has been recommended, to avoid such events, the 
planning and implementation of the transfer into adult care should be carefully prepared and 
smoothed11. The concept of ‘transition to adult care’ covers the purposeful process beginning 
in childhood and ending in adulthood during which the patient switches to, and is accepted by, 
adult healthcare services. 
In a comprehensive approach to patient management, evaluations of successful transition to 
adult care should be multidimensional, both for individual patients and for evaluations of the 
transition program. Relevant outcomes, identified by Delphi method12 and literature 
reviews13,14,  may include the patient building a trusting relationship with an adult care 
provider, continuing attention to self-management, clinical outcomes (such as unplanned 
health care use), biological outcomes (HbA1c in diabetes), the satisfaction of patients and 
their parents, quality of life  and continuity of care. 
Experts have almost unanimously identified one particular indicator as critical: the patients 
lost to follow-up12. Indeed, continuity of care is a core issue for patients transferring from 
pediatric to adult care systems. It has been shown to be related to patient satisfaction, a lower 
frequency of hospital admissions and emergency department visits and a greater use of 
preventive services15. Appropriate outcomes are therefore required for the evaluation of 
continuity of care in patients with childhood-onset chronic diseases transferring to adult care. 
Such outcomes are required, in particular, for the comparison of processes and transfer 
success by time period, country and care organization with or without structured transition 
programs, and according to disease-related and socio-demographic factors. Appropriate 
outcomes are also required for evaluating the efficacy of transition programs in randomized 
studies.  
In 2006, a systematic review identified various continuity of care indices used in pediatric 
studies, which could be grouped into five categories: duration, density, dispersion, sequence, 
and subjective16. The most common were density indices, measuring contacts with the usual 
provider of care. However, this review did not focus on patients with chronic diseases and, 
more importantly, did not consider continuity of care at the time of transfer to adult care. As 
this period may correspond to changes in the medical team and, in some cases, in the 
geographic site at which care is provided, specific continuity of care outcomes would 
probably be more appropriate. 
We carried out a systematic literature review, addressing the issue of care continuity in patient 
with a chronic disease, during the transfer to adult care. Our main objective was to identify 
the strengths and limitations of the various continuity of care outcomes used in both 
interventional and non-interventional studies, to harmonize and improve the quality of future 
research on the transition to adult care. A secondary objective was to analyze whether 
published studies provide evidence regarding the efficacy of structured transition programs in 
terms of care continuity.   
METHODS 
Criteria for the identification of studies for this review 
We considered original studies (interventional or non-interventional) including quantitative 
data and addressing the transition from pediatrics to adult care of patients with chronic 
diseases.  
Studies had to meet the following criteria for inclusion in this review: 1) Some or all of the 
patients included had to have a long-term health condition requiring ongoing healthcare; 2) 
Patient care was initiated in a pediatric department; 3) At least one indicator of continuity of 
care with the usual provider of care was reported; 4) The study was not limited to continuity of 
care in a pediatric department.  
We excluded studies that included only fully institutionalized patients, patients suffering from 
a primary mental disease, or treated for cancer in childhood. In the two first cases, the 
conditions concerned have a direct impact on the autonomy of the patient in terms of care 
continuity and transfer to adult services. For cancer patients, long-term follow-up is justified 
principally by the need to check for relapses and complications of treatment in the long term.  
 
Search methods for identification of studies 
We searched for references with Pubmed (1948-2014), Web of Science (1945-2014) and 
EMBASE (1947-2014), using the search strategy described in Supplemental Table 6 together 
with an algorithm developed by McPheeters et al.13. Sensitivity was maximized by the use of 
an algorithm searching for articles addressing the topic of the transition to adult care. As we 
wished to identify all the studies dealing with chronic diseases, no matter what the disease, 
and all the continuity of care outcomes studied, we did not use keywords to select specific 
diseases or specific outcomes. The papers selected had to have been published in English or 
French. Finally, we searched the reference lists of the selected articles.  
 
Data collection and analysis 
Selection of studies 
One reviewer (the first author, AR) downloaded all records identified by the electronic 
searches to the reference management database Zotero (version 4.0), and removed duplicates. 
He performed a preliminary screening of the titles and abstracts and excluded irrelevant 
references (those not corresponding to original articles addressing any aspect of the transition 
to adult care in patients with a chronic condition). The full-text manuscripts of the selected 
references were downloaded when possible. If not, we contacted the corresponding authors by 
e-mail to obtain a copy of the article. If no response had been obtained after two e-mails had 
been sent, the article was considered to be unavailable.  
Two reviewers, systematically including AR and one of DL, JW and PD, independently 
assessed the full texts for the inclusion criteria and extracted data, and evaluated the risks of 
bias of each of the studies included. Disagreements were resolved by discussion between 
reviewers, or arbitration by a third reviewer. 
 
Data extraction and management 
A standardized electronic data extraction form was adapted from the Cochrane Effective 
Practice and Organization of Care (EPOC) data extraction form 
(http://epoc.cochrane.org/epoc-specific-resources-review-authors), which was created for 
reviews of interventional studies. AR and JW tested this form with three articles and adapted 
it according to the results obtained. The data extracted included study design and settings, 
study population, continuity of care outcomes, their mode of collection and a comprehensive 
risk of bias assessment. 
 
Assessment of the risk of bias for the studies included 
We used the criteria defined in the “Cochrane handbook for systematic reviews of 
interventions” (http://handbook.cochrane.org/). However, these criteria were defined for 
interventional trials and do not cover all potential sources of bias found in observational 
studies. We therefore assessed four additional standardized criteria: inadequate measurement 
of risk factors (whereas only the inadequate measurement of outcomes was considered in the 
Cochrane Handbook), inappropriate eligibility criteria according to the target population, lack 
of participation of eligible subjects, and confounding bias (which is not explicitly mentioned 
in the Cochrane Handbook). Each type of bias was assessed only when appropriate, according 
to the study design. For instance, risk of confounding was assessed for non-randomized 
comparative studies only. The detailed definitions and applicability of the risk of bias 
assessment are reported in Supplemental Table 7. 
 
Review synthesis 
We first described the characteristics of the studies included. By informal consensus, we 
grouped the indicators used in the different studies into several types of outcome 
corresponding to different aspects of continuity of care. The results of the studies are 
presented by type of outcome and according to whether or not the patients were cared for 
within a structured transition program, i.e., which refers to an explicit transition policy13. For 
example, this was the case in a study evaluating a young person clinic (structured transition) 
compared to no young person clinic (unstructured transition)5. Because of the heterogeneity of 
the study designs, we assessed the risks of bias separately for cross-sectional studies (repeated 
or not), cohort studies, and randomized controlled trials, using Cochrane reports figures. 
Justifications given by the authors who assessed the risks of bias were also summarized. 
The review protocol is available on demand (in French).  
RESULTS 
Results of the search  
As shown on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA, http://prisma-statement.org) flow chart (Figure 1), the electronic searches yielded 
3736 non-duplicate records, 3539 of which were deemed irrelevant following a preliminary 
screening of titles and abstracts. We excluded 173 of the remaining 197 records after full-text 
assessment: 168 of the excluded studies focused exclusively on outcomes other than 
continuity of care, such as readiness for transfer, patient satisfaction, quality of life, perceived 
needs, biological (often HbA1c in patients with diabetes) or clinical health status. Finally, 24 
articles relating to 23 studies were considered eligible and were included in this review. Two 
articles reported results from the same study17,18. No additional articles were retrieved from 
searches of the reference lists of these 24 articles. 
 
Study designs, settings and study populations 
The objective was exclusively descriptive in four studies (17%). In the others, the aim was to 
identify factors associated with outcome (12 studies, 52%) or to evaluate structured transition 
programs (7 studies, 30%) (Supplemental Tables 8 and 9). With the exception of one 
randomized trial, all the studies were observational: 15 retrospective cohorts, one cohort that 
was both retrospective and prospective and six cross-sectional studies. Most of the studies 
were performed in North America and Europe (N=22). Three of the studies focused on the 
general population, whereas the others involved patient recruitment at hospitals (pediatric 
units in 8 studies, adult care units in 6, and both types of unit in 4). All but five of the studies 
were carried out at single centers. The principal diseases studied were diabetes (11 
studies6,17,19–27 with 26 to 250 patients; 1148 overall), congenital heart disease (4 studies28–31 
with 153 to 794 patients; 1465 overall) and sickle cell disease (3 studies32–34 with 18 to 83 
patients; 148 overall). The other diseases studied were rheumatic diseases (131 patients in 2 
studies35,36), congenital adrenal hyperplasia (53 patients5) and cystic fibrosis (68 patients37). 
One study38 included youths with special health care needs (n=1865 participants) due to 
various diseases (i.e., it was not specific to a particular disease). 
 
Outcomes measuring continuity of care 
A total of 24 different indicators of continuity of care were reported in the included studies 
(Table 1): 7 related to engagement in adult care, 14 to retention in adult care and 3 
corresponding to a combination of outcomes. Engagement in adult care comprised indicators 
of attendance at the first or the first two adult care unit visits and indicators of time between 
the last pediatric and the first adult visit. Retention in adult care was measured by the 
frequency of visits and attendance at scheduled clinic appointments. 
 
Engagement in adult care  
The percentages of patients attending the first or the first two adult care visits were reported in 
eight studies (Table 2). The proportion of patients attending the first adult care visit ranged 
from 56% to 79% with a structured transition and from 47% to 100% with an unstructured 
transition. The proportion of patients attending the first two adult care visits was reported in 
only one study: 56% of 34 patients with congenital adrenal hyperplasia5. Two studies, 
including the latter, compared structured and unstructured transitions and reported no 
significant difference between these two types of transition5,21. 
The time between the last pediatric visit and the first adult visit, reported in 10 studies (Table 
3), was highly variable, as were the results, even for a single disease. Structured and 
unstructured transitions were compared in three studies: there was a shorter time between 
these two visits in structured transition conditions in two studies, on diabetes25 and sickle cell 
disease33, whereas no significant difference was found between structured and unstructured 
transitions in the third study21, which focused on diabetes. 
 
Retention in adult care after transfer 
Retention in adult care once the first contact had been established was reported in 14 studies, 
evaluated at one year after transfer in eight studies, 15-18 months in one study, two years in 
three studies and at least three years after transfer in four studies.  
The frequency of visits, reported in eight studies (Table 4), was lower in adult than pediatric 
care in two studies on diabetes6,23, whereas it was the opposite in one study on cystic 
fibrosis37. The frequency of adult care visit did not differ significantly between structured and 
unstructured transitions in two studies19,21. 
Attendance at scheduled clinic appointments after transfer, reported in five studies (Table 5), 
was measured as the mean percentage of scheduled appointments attended per year in two 
studies5,25, as the proportion of patients attending appointments at one year35 or two years36, or 
as the number of failed appointments26. One study on diabetes found a trend towards better 
attendance after structured than after unstructured transition25. 
 
Combined outcomes (not shown in tables)  
Three studies used more complex outcomes (Table 1). In one study, also cited in Tables 2 and 
5, the authors defined a combined indicator based on both engagement and retention in adult 
care: “failure to make initial contact with an adult rheumatologist, or failure to continue to 
follow-up with an adult rheumatologist two years after transfer (no contact for a one year 
period after the last scheduled appointment)”36. The other two studies are cited in Table 1 
only. The first addressed current follow-up in adult care, without indicating the proportions of 
patients lost-to-follow up before and after the first contact with the adult care unit31. The 
second used a composite outcome including clinical attendance, access to a health insurance, 
self-perception of care and delayed care38.  
 
Risk of bias  
The risks of bias are presented by study on Figure 2 and according to type of design in 
Supplemental Figures 3 and 4. 
All cross-sectional studies presented a high risk of selection bias, because they involved the 
recruitment of patients from adult services. Those who were lost to clinical follow-up during 
the transfer were thus missing. There was a high risk of confounding for all studies with 
comparative objectives, because multivariate analyses were either absent or inappropriate in 
these studies (often due to the limited data or number of patients included). Classification bias 
due to errors in the measurement of outcome and/or risk factors, which were collected 
retrospectively by interview, were also frequent. 
In cohort studies, the most frequent bias was confounding, for the same reasons as in cross-
sectional studies. The second main limitation was a potential selection bias due to high non-
participation rates for eligible patients (e.g., 82.5% in Oswald 201338). In most of these 
studies, patients were identified retrospectively from their previous pediatric files and some 
did not respond to letters or phone calls, with these attempts at contact made several years 
after transfer to adult care in some cases. Finally, there may have been a potential 
classification bias, due to the retrospective collection of data relating to transfer history. 
The main limitation of the only randomized trial included in this review related to the 
extremely low proportion of eligible patients who agreed to participate, corresponding to only 
half the planned number, resulting in insufficient statistical power and calling into question 
the generalizability of the results.  
DISCUSSION 
We retrieved only 23 studies addressing the issue of care continuity in youths with chronic 
conditions transferring from pediatric to adult healthcare services. Although the transition 
issue concerns a large spectrum of chronic diseases, most of these studies included patients 
with diabetes or congenital heart disease, and many chronic diseases were not studied (HIV 
infection, hemophilia, inflammatory bowel disease, etc.). All the studies reported indicators 
related to either engagement or retention in adult care.  
Engagement in adult care was measured using probability of, and/or time to, attendance at the 
first visit to adult care. Delays in adult care attendance has been pointed out by a panel of 
experts, who considered as “very important” to measure “patient’s first visit in adult care no 
later than 3-6 months after transfer”12. This was done in five of the studies reported here. 
Furthermore, these timelines seem to reflect follow-up periods advocated by various disease 
organizations39,40. Using a - partly arbitrarily - time cutoff provides a goal to be achieved in 
transition programs. Follow-up of patients initially recruited in a pediatric department and the 
use of survival analysis to take into account censored data due to deaths and patients lost-to-
follow up are required to avoid an overestimation of the probability of attendance and 
underestimation of transfer time. Nine cohorts that included patients in pediatrics measured 
engagement, but none of them performed a survival analysis. 
Retention in adult care after transfer was measured using the frequency of visits and the 
attendance at scheduled appointments. Both are indicators of healthcare use, which is likely to 
be positively associated with disease severity. Attendance at scheduled appointments 
measures more specifically compliance with care and was considered as very important by the 
panel of experts, who defined it as “no missed consultations previously canceled and 
rescheduled”12. It was reported in five of the studies reviewed here. However, such an 
indicator is hard to collect because missed visits are rarely indicated in patient records. 
Measuring retention indicators in both pediatric and adult department for each patient, as done 
in 7 studies, is the only way to study whether adherence with care is maintained, improved or 
altered after transfer.  
Interestingly, engagement and retention in adult care correspond to two key challenges of 
transfer: ensuring continuity between pediatric and adult care, a type of “cross-boundary 
continuity”41, and build a new patient-provider relationship, i.e., initiate a new “relational 
continuity”42,43. Some authors have also considered informational continuity, corresponding to 
the availability of information about medical history to ensure appropriate care42. This aspect 
was not described in the studies reviewed here.  
Several instruments measuring care continuity have been developed in other contexts, 
including the Diabetes Continuity of Care Questionnaire, Alberta Continuity of Services 
Scale-Mental Health, Heart Continuity of Care Questionnaire, and Nijmegen Continuity 
Questionnaire41. Their relevance to the transfer to adult care and their validity in youths with 
chronic diseases should be evaluated. Besides, several authors suggest to develop subjective 
measures of continuity41,42. 
There was little data available to evaluate the difference in continuity of care outcomes 
between structured and unstructured programs. Two studies found a shorter transfer time25,33 
and better attendance in adult care33 for patients involved in a structured transition program 
than those with no structured transition. However, both studies were not randomized, so we 
cannot exclude that these encouraging results are partly explained by an indication bias. No 
difference was reported in the three other studies that compared structured and unstructured 
transition, including the randomized controlled trial5,19,21. Nevertheless they concerned small 
numbers of patients. We cannot rule out that there would have been a significant difference if 
the studies had been more highly powered. Finally, it seems impossible to perform inter-study 
comparisons of continuity of care across various types of transition, because of the large 
heterogeneity of care context, study populations, designs, and indicators used. The 
methodological limitations of the studies impede the extrapolation of the results for the same 
disease in other contexts, and even more so for other diseases. 
One limitation of this review is the lack of inclusion of grey literature (kind of material that is 
not published in easily accessible journals or databases). However, our electronic search 
strategy was very sensitive, as reflected by the lack of identification of any other eligible 
studies in the reference lists of the articles included. Assessment of the risk of bias was 
challenging, due to the heterogeneity and observational nature of the studies included. We 
tried to limit the subjective dimension of assessment, by developing a standardized 
questionnaire based on the Cochrane risk of bias assessment, with additional criteria more 
specific to observational epidemiologic studies (Supplemental Table 7). This questionnaire 
was completed independently, by two reviewers. This extended risk of bias assessment tool is 
not specific to the issue addressed here. It could thus be used in systematic reviews of 
observational studies in other contexts. 
  
CONCLUSIONS 
This review highlights the current lack of knowledge about the efficacy of structured 
transition programs for ensuring continuity of care during transfer from pediatric to adult care. 
The outcomes identified in this review are relevant and can be used for any other chronic 
conditions or other types of healthcare transitions, because they are not specific to a particular 
disease. This may facilitate comparisons of results obtained in different contexts and at 
different times. To avoid an overestimation of successful engagement in adult care, all 
patients lost to clinical follow-up during the transfer from pediatric care have to be identified. 
However, there are few prospective cohorts with the initial recruitment of patients in pediatric 
departments. Such designs and randomized trials are needed to compare adherence with care 
before and after the transfer and to evaluate the role of structured transition programs.  
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow 
chart 
 
 
 
 
  
Figure 2. Risk of bias summary 
Review authors’ judgements about each risk of bias item for each included study. Red circles: 
high risk; green circle: low risk; yellow circles: unclear; empty: not concerned 
 
 
Table 1. Reported outcomes and indicators of continuity of care 
 
Type of 
outcome 
Outcome Indicator References 
Engagement 
in adult care 
Attendance at the first visit in adult care Proportion 
Andemariam 2014, Kipps 
2002, Hazel 2010, Hersh 2009, 
Reid 2004, Wojciechowski 
2002, Steinbeck 2014 
Attendance at the first two visits in adult care Proportion Gleeson 2013 
Time between the last pediatric visit and the first adult 
visit 
Mean (+/- SD) 
Vanelli 2004, Wojciechowski 
2002, Cadario 2009 
Median (+/- IQR) 
Hersh 2009, Wojciechowski 
2002, Yeung 2008, Steinbeck 
2014 
Proportion < 3 months Stanczyk 2014, Hankins 2012 
Proportion < 6 months 
Garvey 2012 & 2013a, Garvey 
2013b, Stanczyk 2014 
Proportion < 24 months Yeung 2008 
Retention in 
adult care 
Frequency of visits 
Mean (+/- SD) per year Dugueperoux 2008, Busse 2007 
Median (+/- IQR) per year Steinbeck 2014 
Proportion ≥ 3-4 monthly Kipps 2002 
Proportion ≥ 6 monthly Kipps 2002 
Proportion with ≥ 1 cardiology clinic visit within 2 years 
of study interview 
Norris 2013 
Proportion with no 2-year interval without cardiac care Norris 2013 
Proportion with no delay >12 months between 2 visits Pacaud 2005 
Proportion with ≥ 1 visits per year Van Walleghem 2008 
Proportion with ≥2 visits per year Pacaud 2005 
Proportion with 1-2 or ≥3 visits per year Stanczyk 2014 
Attendance at scheduled clinic appointments 
Mean percentage of scheduled clinic appointments 
attended by year 
Gleeson 2013, Cadario 2009 
Proportion with 0-1/2/≥3 failed appointments Johnston 2006 
Proportion attending at least one scheduled clinic 
appointment in the 2 years following transfer 
Hazel 2010 
Proportion attending all their scheduled clinic 
appointments 
Hersh 2009 
Other 
Unsuccessful transfer: failure to make initial contact 
with an adult rheumatologist, or failure to continue to 
follow-up with an adult rheumatologist two years after 
transfer (no contact for a one year period after the last 
scheduled appointment) 
Proportion Hazel 2010 
Follow-up in adult care: patients indicated that they 
were currently in cardiac follow-up or they could be 
contacted by mail or phone. 
Proportion Goossens 2011 
Successful transition:   
(has usual health care source or has usual routine 
preventive care source or has a personal doctor or 
nurse) and (his/her doctor does not treat only children, 
teens, or young adults) and (he/she has had continuous 
health insurance coverage for the past 12 months) and 
(health insurance benefits meet his/her needs) and 
(he/she had at least 1 preventive health care visit in the 
last 12 months) and (he/she is satisfied with health 
services) and (needed health care was not 
delayed/foregone in the last 12 months) 
Proportion Oswald 2013 
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Table 2. Engagement in adult care: attendance at the first or first two adult care visits (n=8 studies) 
 
Reference Population and design Data collection Type of transition 
Indicator of attendance at the firsta adult 
care visit 
Andemariam 
2014 
SCD; USA;  
Retrospective cohort; N=47 Retrospective chart review Structured Proportion: 68% 
Kipps 2002 
Diabetes; UK; 
Retrospective cohort; N=141 Retrospective chart review Structured Proportion: 79% 
Hazel 2010 
Rheumatic disease; Canada;  
Retrospective cohort; N=100 
Retrospective chart review, 
Interview with healthcare 
provider Unstructured Proportion: 83% 
Hersh 2009 
Rheumatic disease; USA; 
Cross-sectional; N=31 
Retrospective chart review, 
administrative database Unstructured Proportion: 71% 
Reid 2004 
CHD; Canada;  
Retrospective cohort; N=360 Administrative database Unstructured Proportion: 47% 
Wojciechowski 
2002 
SCD; USA;  
Retrospective cohort; N=47 
Interview with health care 
provider Unstructured Proportion: 61% 
Gleeson 2013 
CAH; UK;  
Retrospective cohort; N=34 
Retrospective chart review, 
administrative database 
Young person clinic vs. no young 
person clinic Proportion: 56%$$ (not reported by group) 
Steinbeck 2014 
Diabetes; Australia;  
RCT; N=26 Unclear 
Comprehensive transition program 
vs. standard clinical practice Proportions: 79% vs. 100%$$ 
*p<0.05; **p<0.01; ***p<0.001; $p<0.10; $$p≥0.10 (or reported as no significant difference with no p-value). aexcepted for Gleeson 2013, which reported 
attendance at the first two adult care visits. Abbreviations: CAH, congenital adrenal hyperplasia; CHD, congenital heart disease; RCT, randomized controlled 
trial; SCD, sickle cell disease 
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Table 3. Engagement in adult care: time between last pediatric and first adult visit (n=10 studies) 
 
Reference Population and design Data collection Type of transition 
Indicators of time between 
last pediatric and first adult 
visit 
Vanelli 2004 
Diabetes; Italy;  
Cross-sectional; N=64 Telephone interview with the patient Structured 
Mean±SD: 26.4 ± 25.2 
months 
Garvey 2012 & 
2013a 
Diabetes; USA;  
Cross-sectional; N=250 
Web-based and non-web-based 
autoquestionnaires Unstructured Proportion ≤ 6 months: 66% 
Garvey 2013b 
Diabetes; USA;  
Retrospective cohort; N=61 
Web-based and non-web-based 
autoquestionnaires Unstructured Proportion ≤ 6 months: 74% 
Hersh 2009 
Rheumatic disease; USA; 
Cross-sectional; N=31 
Retrospective chart review, 
administrative database Unstructured Median: 7.1 months 
Stanczyk 2014 
Diabetes; Poland; 
Retrospective cohort; N=114 
Telephone interview with the patient, 
non-web-based autoquestionnaire Unstructured 
Proportion < 3 months: 84% 
Proportion ≤ 6 months: 91% 
Wojciechowski 
2002 
SCD; USA;  
Retrospective cohort; N=18 Interview with healthcare provider Unstructured 
Mean±SD: 6.2 ± 7.7 months  
Median: 2 months 
Yeung 2008 
CHD; USA; 
Cross-sectional; N=158 
Face-to-face interview with the patient, 
proxy interview (parents, etc.) Unstructured 
Proportion < 24 months: 37% 
Median: 120 months 
Hankins 2012 
SCD; USA;  
Retrospective cohort; Na Unclear 
Before Transition Pilot Program 
implementation: unstructured (N=75) Proportion < 3 months: 15% 
Participation to Transition Pilot 
Program vs. no participation (N=83) 
Proportions < 3 months: 74% 
vs. 33%*** 
Cadario 2009 
Diabetes; Italy;  
Cross-sectional; N=62 Administrative database Structured vs. unstructured transition 
Mean±SD: 9.6 ± 7.2 months 
vs. 55.2 ± 14.4 months*** 
Steinbeck 2014 
Diabetes; Australia;  
RCT; N=18 Unclear 
Comprehensive transition program 
vs. standard clinical practice 
Median (IQR): 3.4 (1.8-4.4) 
months vs. 3.2 (2.5-4.6) 
months$$ 
 
*p<0.05; **p<0.01; ***p<0.001; $p<0.10; $$p≥0.10 (or reported as no significant difference with no p-value). aN specified in “type of transition” column. 
Abbreviations: CHD, congenital heart disease; IQR, interquartile range; RCT, randomized controlled trial; SCD, sickle cell disease; SD, standard deviation 
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Table 4. Retention in adult care after transfer: frequency of visits (n=8 studies) 
Reference Population and design Data collection Type of transition Indicators of frequency of visitsa 
Dugueperoux 
2008 
CF; France;  
Repeated cross-sectional; N=68 Retrospective chart review Structured 
1y before transfer: mean 3.8 /y 
1y after transfer: mean 8.7 /y*** 
Kipps 2002  
Diabetes; UK;  
Retrospective cohort; N=96 Retrospective chart review Structured 
Proportion ≥ 3-4 monthly:  
  2y before transfer: 77% 
  1y before transfer: 54% 
  1y after transfer: 45% 
  2y after transfer: 24%*** 
Proportion ≥ 6 monthly:  
  2y before transfer: 98% 
  1y before transfer: 87% 
  1y after transfer: 81% 
  2y after transfer: 61%*** 
Busse 2007 
Diabetes; Germany;  
Retrospective cohort; N=101 
Telephone interview with the patient, 
retrospective chart review Unstructured 
Before transfer: mean±SD: 8.5 ± 2.3 /y 
After transfer: mean±SD: 6.7 ± 3.2 /y* 
Norris 2013 
CHD; USA;  
Retrospective cohort; N=153 
Telephone interview with the patient, 
retrospective chart review, proxy 
interview (parents, etc.) Unstructured 
Proportion with ≥ 1 cardiology clinic visit 
within 2 years of study interview: 82%; 
Proportion with no 2-year interval 
without cardiac care: 76% 
Pacaud 2005 
Diabetes; Canada;  
Retrospective cohort; N=214 Non-web-based autoquestionnaire Unstructured 
Proportion with no delay >12 months 
between 2 visits: 90%; proportion with ≥2 
visits/y: 87% 
Stanczyk 
2014 
Diabetes; Poland;  
Retrospective cohort; N=132 
Telephone interview with the patient, 
non-web-based autoquestionnaire Unstructured 
Proportion with 
  1-2 visits/y: 87% 
  ≥ 3 visits/y: 13% 
Steinbeck 
2014 
Diabetes; Australia;  
RCT; N=18 Unclear 
Comprehensive transition 
program vs. standard 
clinical practice Median (IQR): 3 (2-5) /y vs. 2 (1-4) /y$$ 
Van 
Walleghem 
2008 
Diabetes; Canada;  
Retrospective and prospective 
cohort; N=64 
Telephone interview with the patient, 
retrospective chart review, 
administrative database Before vs. after Maestro 
Proportion with ≥ 1 visits /y: 89% vs. 
95%$$ 
*p<0.05; **p<0.01; ***p<0.001; $p<0.10; $$p≥0.10 (or reported as no significant difference with no p-value). ain adult care unless otherwise specified. 
Abbreviations: CF, cystic fibrosis; CHD, congenital heart disease; IQR, interquartile range; RCT, randomized controlled trial; SD, standard deviation 
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Table 5. Retention in adult care after transfer: attendance at scheduled clinic appointments (n=5 studies) 
 
Reference Population and design Data collection Type of transition 
Indicators of attendance at scheduled clinic 
appointmentsa 
Gleeson 
2013 
CAH; UK;  
Retrospective cohort; N=23 
Retrospective chart review, 
administrative database Structured 
Mean percentage of scheduled clinic 
appointments attended by yearb: 
  3y before transfer: 81% 
  2y before transfer: 90% 
  1y before transfer: 90% 
  1y after transfer: 20% 
  2y after transfer: 25% 
  3y after transfer: 40%** 
Johnston 
2006 
Diabetes; UK;  
Retrospective cohort; N=33 Administrative database Structured 
2y before transfer, proportion with 
  0-1 failed appointment: 52% 
  2 failed appointments: 18% 
  ≥3 failed appointments: 30% 
15-18m after transfer, proportion with 
  0-1 failed appointment: 20% 
  2 failed appointments: 40% 
  ≥3 failed appointments: 40% 
Hazel 2010 
Rheumatic disease; Canada;  
Retrospective cohort; N=100 
Retrospective chart review, interview 
with the healthcare provider Unstructured 
Proportion attending at least one scheduled 
clinic appointment in the 2 years following 
transfer: 65% 
Hersh 2009 
Rheumatic disease; USA;  
Cross-sectional; N=31 
Retrospective chart review, 
administrative database Unstructured 
Proportion attending all their scheduled clinic 
appointments: 
  1y before transfer: 68% 
  1y after transfer: 68% 
Cadario 2009 
Diabetes; Italy;  
Cross-sectional; N=62 Administrative database 
Structured Vs. 
unstructured transition 
Mean±SD percentage of scheduled clinic 
appointments attended by year: 
  Before transfer: 79% ± 3% vs. 80% ± 4%$$ 
  After transfer: 80% ± 12.5% vs. 57% ± 5%* 
 
*p<0.05; **p<0.01; ***p<0.001; $p<0.10; $$p≥0.10 (or reported as no significant difference with no p-value). ain adult care unless otherwise specified. bvalues not  
given (approximations from a figure). Abbreviations: CAH, congenital adrenal hyperplasia; RCT, randomized controlled trial; SD, standard deviation 
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Supplementary Data 
 
 
 
 
Supplemental Figure 3. Risk of bias graphs in cross-sectional studies (N=6) 
 
 
 
Review authors’ judgement about each risk of bias item presented as percentages across all included cross-sectional studies. White corresponds to 
the studies that were not concerned by the corresponding type of bias. 
 
 
 
 
 
Supplemental Figure 4. Risk of bias graphs in cohort studies (N=15) 
 
 
 
Review authors’ judgement about each risk of bias item presented as percentages across all included cohort studies. The randomized trial is counted 
in the studies of this figure (Steinbeck 2014). White corresponds to the studies that were not concerned by the corresponding type of bias. 
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Supplemental 6. Pubmed search algorithm 
 
1. (“Transition to adult care” [Mesh] OR “Transition to adult care” [Title/Abstract] OR transition* [Title] 
OR transfer* [Title] OR "continuity" [Title/Abstract] OR "continuity of patient care" [Mesh] OR 
"continuity of patient care" [Title/Abstract] OR "patient transfer" [Mesh] OR "patient transfer" 
[Title/Abstract] OR "patient care planning" [Mesh] OR "patient care planning" [Title/Abstract]) 
2.  ("adolescent" [Mesh] OR "adolescent" [Title/Abstract] OR "young adult" [Mesh] OR "young adult" 
[Title/Abstract] OR "adolescents" [Title/Abstract] OR "adolescence" [Title/Abstract] OR "teen" 
[Title/Abstract] OR "teens" [Title/Abstract] OR "teenage" [Title/Abstract] OR "teenager" 
[Title/Abstract] OR "juvenile" [Title/Abstract] OR "youth" [Title/Abstract] OR "young person" 
[Title/Abstract] OR "young persons" [Title/Abstract] OR "young people" [Title/Abstract] OR "young 
adult" [Title/Abstract] OR "young adults" [Title/Abstract] OR "young adulthood" [Title/Abstract] OR 
"young men" [Title/Abstract] OR "young women" [Title/Abstract] OR "young male" [Title/Abstract] 
OR "young males" [Title/Abstract] OR "young female" [Title/Abstract] OR "young females" 
[Title/Abstract] OR "pediatric" [Title/Abstract] OR "pediatrics" [Mesh] OR "pediatrics" [Title/Abstract] 
OR "paediatric" [Title/Abstract] OR "paediatrics" [Title/Abstract] OR "adolescent medicine" [Mesh] 
OR "adolescent medicine" [Title/Abstract] OR "adolescent health services" [Mesh] OR "adolescent 
health services" [Title/Abstract] OR "hospitals, pediatric" [Mesh] OR "hospitals, pediatric" 
[Title/Abstract]) 
3. adult* [Title/Abstract] 
4.  (“health facilities” [Mesh] OR “patient care management” [Mesh] OR “medicine” [Title/Abstract] OR 
“care” [Title/Abstract] OR “health care” [Title/Abstract] OR “healthcare” [Title/Abstract] OR “service” 
[Title/Abstract] OR “services” [Title/Abstract] OR “centre” [Title/Abstract] OR “centres” 
[Title/Abstract] OR “center” [Title/Abstract] OR “centers” [Title/Abstract] OR “clinic” [Title/Abstract] 
OR “clinics” [Title/Abstract] OR “facility” [Title/Abstract] OR “facilities” [Title/Abstract] OR “unit” 
[Title/Abstract] OR “units” [Title/Abstract] OR “department” [Title/Abstract] OR “departments” 
[Title/Abstract] OR “hospital” [Title/Abstract] OR “hospitals” [Title/Abstract] OR program* 
[Title/Abstract]) 
5. English [la] OR French [la] 
6. 1. AND 2. AND 3. AND 4. NOT "review" [Publication Type] 
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Supplemental Table 7. Definitions of the risks of bias 
 
Domain 
Concerned 
studies 
Support for 
Judgement 
Review 
authors’ 
judgement 
Criteria for the judgement of ‘High 
risk’ of bias. 
Criteria for a judgement of ‘Low 
risk’ of bias. 
Criteria for the judgement 
of  ‘Unclear risk’ of bias 
Inappropriate 
eligibility 
criteria 
Non-
randomized 
studies 
List inclusion and 
exclusion criteria 
Study 
population not 
representative 
of target 
population 
At least one inclusion or exclusion 
criterion that is not related to target 
population and that could be 
associated with the outcome 
(continuity of care) 
Inclusion and exclusion criteria are 
not likely to select a particular 
population which would be different 
from the target population for 
characteristics related to the 
outcome (continuity of care) 
Insufficient information to 
permit judgement of ‘Low 
risk’ or ‘High risk’ (eg, 
inclusion and exclusion 
criteria not specified or 
target population difficult 
to define). 
Participation 
Non-
randomized 
studies 
Describe the method 
used to recruit 
subjects. 
Included 
subjects not 
representative 
of eligible 
subjects 
The recruitment did not allow to 
make a representative sample of 
the study population. Participants 
that were recruited were likely to 
differ from those who were not for 
characteristics related to the 
outcome. This bias should be 
suspected, for example, when there 
is one or several of these elements: 
- a high rate of non-response or 
non-participation,  
- a recruitment that was not at 
random 
- the study was not proposed to 
consecutive eligible subjects 
Recruitment that is likely to have 
resulted in a representative sample 
of the study population 
Insufficient information to 
permit judgement of ‘Low 
risk’ or ‘High risk’ (eg, 
recruitment not 
described). 
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Supplementary Table 7. (continued) 
 
Domain 
concerned 
studies 
Support for judgement 
Review 
authors’ 
judgement 
Criteria for the judgement of ‘High 
risk’ of bias. 
Criteria for a judgement of ‘Low 
risk’ of bias. 
Criteria for the judgement 
of  ‘Unclear risk’ of bias 
Incomplete 
outcome 
data 
All 
Describe the 
completeness of 
outcome data for each 
main outcome, 
including attrition and 
exclusions from the 
analysis. State 
whether attrition and 
exclusions were 
reported, the numbers 
in each intervention 
group (compared with 
total randomized 
participants), reasons 
for attrition/exclusions 
where reported, and 
any re-inclusions in 
analyses performed 
by the review authors. 
Attrition bias 
due to 
amount, 
nature or 
handling of 
incomplete 
outcome 
data. 
Any one of the following: 
-    Reason for missing outcome 
data likely to be related to true 
outcome, with either imbalance in 
numbers or reasons for missing 
data across intervention groups; 
-    For dichotomous outcome data, 
the proportion of missing outcomes 
compared with observed event risk 
enough to induce clinically relevant 
bias in intervention effect estimate; 
-    For continuous outcome data, 
plausible effect size (difference in 
means or standardized difference in 
means) among missing outcomes 
enough to induce clinically relevant 
bias in observed effect size; 
-    ‘As-treated’ analysis done with 
substantial departure of the 
intervention received from that 
assigned at randomization; 
-    Potentially inappropriate 
application of simple imputation. 
Any one of the following: 
-    No missing outcome data; 
-    Reasons for missing outcome 
data unlikely to be related to true 
outcome (for survival data, 
censoring unlikely to be introducing 
bias); 
-    Missing outcome data balanced 
in numbers across intervention 
groups, with similar reasons for 
missing data across groups; 
-    For dichotomous outcome data, 
the proportion of missing outcomes 
compared with observed event risk 
not enough to have a clinically 
relevant impact on the intervention 
effect estimate; 
-    For continuous outcome data, 
plausible effect size (difference in 
means or standardized difference 
in means) among missing 
outcomes not enough to have a 
clinically relevant impact on 
observed effect size; 
-    Missing data have been 
imputed using appropriate 
methods. 
Any one of the following: 
-    Insufficient reporting of 
attrition/exclusions to 
permit judgement of ‘Low 
risk’ or ‘High risk’ (e.g. 
number randomized not 
stated, no reasons for 
missing data provided); 
-    The study did not 
address this outcome. 
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Supplementary Table 7. (continued) 
 
Domain 
concerned 
studies 
Support for judgement 
Review 
authors’ 
judgement 
Criteria for the judgement of ‘High 
risk’ of bias. 
Criteria for a judgement of ‘Low 
risk’ of bias. 
Criteria for the judgement 
of  ‘Unclear risk’ of bias 
Classification 
bias for 
outcome 
assessment 
All 
Describe the method 
used to collect and 
measure outcomes, 
including blinding of 
outcome assessment 
in comparative studies 
Classification 
bias due to 
inadequate 
measure of 
outcomes, 
including lack 
of blinding in 
comparative 
studies 
Any one of the following: 
-    Collected by interview with 
healthcare provider or the patient 
(or parents) 
-    In comparative studies, no 
blinding of outcome assessment (or 
blinding broken), and the outcome 
measurement is likely to be 
influenced by lack of blinding 
Any one of the following: 
-    Collected in an exhaustive 
source (eg, registry, electronic 
database) 
-    Collected in patient's chart and 
the review authors judge that the 
outcome measurement is not likely 
to be biased 
 
AND, in comparative studies, one 
of the following: 
-    Blinding of outcome 
assessment ensured, and unlikely 
that the blinding could have been 
broken. 
-    Blinding of outcome 
assessment not ensured, but the 
review authors judge that the 
outcome measurement is not likely 
to be influenced by lack of blinding; 
Insufficient information to 
permit judgement of ‘Low 
risk’ or ‘High risk’; 
Assessment 
of risk 
factors 
observational 
comparative  
Describe the method 
used to collect and 
measure risk factors 
Classification 
bias due to 
inadequate 
measure of 
risk factors 
One of the following: 
- collected retrospectively in 
patient's chart or by interview with 
healthcare provider or the patient 
(or parents), unless the measure 
was obvious (sex, age…) 
- declared prospectively but 
subjective 
One of the following: 
- collected prospectively in an 
adequate manner 
- collected retrospectively in an 
exhaustive source (eg, registry, 
electronic database) 
- objective (sex, age…) 
Insufficient information to 
permit judgement of ‘Low 
risk’ or ‘High risk’. Eg, 
measurement of risk 
factors not described 
Confounding 
observational 
comparative, 
non 
randomized 
evaluation 
Describe the method 
used to take into 
account potential 
confounders 
Confounding 
due to 
confounders 
that were not 
accounted for 
Any one of the following: 
- no particular method to account for 
confounders 
- no multivariate model 
- mutlivariate model that missed 
important confounders 
Multivariate model that included at 
least the most relevant 
confounders 
Insufficient information to 
permit judgement of ‘Low 
risk’ or ‘High risk’ 
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Supplementary Table 7. (continued) 
 
Domain 
concerned 
studies 
Support for judgement 
Review 
authors’ 
judgement 
Criteria for the judgement of ‘High 
risk’ of bias. 
Criteria for a judgement of ‘Low 
risk’ of bias. 
Criteria for the judgement 
of  ‘Unclear risk’ of bias 
Random 
sequence 
generation 
RCT 
Describe the method 
used to generate the 
allocation sequence in 
sufficient detail to 
allow an assessment 
of whether it should 
produce comparable 
groups. 
Selection bias 
(biased 
allocation to 
interventions) 
due to 
inadequate 
generation of 
a randomised 
sequence. 
The investigators describe a non-
random component in the sequence 
generation process. Usually, the 
description would involve some 
systematic, non-random approach, 
for example: 
-    Sequence generated by odd or 
even date of birth; 
-    Sequence generated by some 
rule based on date (or day) of 
admission; 
-    Sequence generated by some 
rule based on hospital or clinic 
record number. 
 
Other non-random approaches 
happen much less frequently than 
the systematic approaches 
mentioned above and tend to be 
obvious.  They usually involve 
judgement or some method of non-
random categorization of 
participants, for example: 
-    Allocation by judgement of the 
clinician; 
-    Allocation by preference of the 
participant; 
-    Allocation based on the results 
of a laboratory test or a series of 
tests; 
-    Allocation by availability of the 
intervention. 
The investigators describe a 
random component in the 
sequence generation process such 
as: 
- Referring to a random number 
table; 
- Using a computer random 
number generator; 
- Coin tossing; 
- Shuffling cards or envelopes; 
- Throwing dice; 
- Drawing of lots; 
- Minimization*. 
 *Minimization may be 
implemented without a random 
element, and this is considered to 
be equivalent to being random. 
Insufficient information 
about the sequence 
generation process to 
permit judgement of ‘Low 
risk’ or ‘High risk’. 
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Supplementary Table 7. (continued) 
 
Domain 
concerned 
studies 
Support for judgement 
Review 
authors’ 
judgement 
Criteria for the judgement of ‘High 
risk’ of bias. 
Criteria for a judgement of ‘Low 
risk’ of bias. 
Criteria for the judgement 
of  ‘Unclear risk’ of bias 
Allocation 
concealment 
RCT 
Describe the method 
used to conceal the 
allocation sequence in 
sufficient detail to 
determine whether 
intervention 
allocations could have 
been foreseen in 
advance of, or during, 
enrolment. 
Selection bias 
(biased 
allocation to 
interventions) 
due to 
inadequate 
concealment 
of allocations 
prior to 
assignment. 
Participants or investigators 
enrolling participants could possibly 
foresee assignments and thus 
introduce selection bias, such as 
allocation based on: 
-    Using an open random allocation 
schedule (e.g. a list of random 
numbers); 
-    Assignment envelopes were 
used without appropriate 
safeguards (e.g. if envelopes were 
unsealed or nonopaque or not 
sequentially numbered); 
-    Alternation or rotation; 
-    Date of birth; 
-    Case record number; 
-    Any other explicitly unconcealed 
procedure. 
Participants and investigators 
enrolling participants could not 
foresee assignment because one 
of the following, or an equivalent 
method, was used to conceal 
allocation: 
-    Central allocation (including 
telephone, web-based and 
pharmacy-controlled 
randomization); 
-    Sequentially numbered drug 
containers of identical appearance; 
-    Sequentially numbered, 
opaque, sealed envelopes. 
Insufficient information to 
permit judgement of ‘Low 
risk’ or ‘High risk’. This is 
usually the case if the 
method of concealment is 
not described or not 
described in sufficient 
detail to allow a definite 
judgement – for example 
if the use of assignment 
envelopes is described, 
but it remains unclear 
whether envelopes were 
sequentially numbered, 
opaque and sealed. 
Blinding of 
participants 
and 
personnel 
RCT 
Describe all measures 
used, if any, to blind 
study participants and 
personnel from 
knowledge of which 
intervention a 
participant received. 
Provide any 
information relating to 
whether the intended 
blinding was effective. 
Performance 
bias due to 
knowledge of 
the allocated 
interventions 
by 
participants 
and 
personnel 
during the 
study. 
Any one of the following: 
-    No blinding or incomplete 
blinding, and the outcome is likely to 
be influenced by lack of blinding; 
-    Blinding of key study participants 
and personnel attempted, but likely 
that the blinding could have been 
broken, and the outcome is likely to 
be influenced by lack of blinding. 
Any one of the following: 
-    No blinding or incomplete 
blinding, but the review authors 
judge that the outcome is not likely 
to be influenced by lack of blinding; 
-    Blinding of participants and key 
study personnel ensured, and 
unlikely that the blinding could 
have been broken. 
Any one of the following: 
-    Insufficient information 
to permit judgement of 
‘Low risk’ or ‘High risk’; 
-    The study did not 
address this outcome. 
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Supplementary Table 7. (continued) 
 
Domain 
concerned 
studies 
Support for judgement 
Review 
authors’ 
judgement 
Criteria for the judgement of ‘High 
risk’ of bias. 
Criteria for a judgement of ‘Low 
risk’ of bias. 
Criteria for the judgement 
of  ‘Unclear risk’ of bias 
Selective 
reporting 
All 
State how the 
possibility of selective 
outcome reporting 
was examined by the 
review authors, and 
what was found. 
Reporting 
bias due to 
selective 
outcome 
reporting. 
Any one of the following: 
-    Not all of the study’s pre-
specified primary outcomes have 
been reported; 
-    One or more primary outcomes 
is reported using measurements, 
analysis methods or subsets of the 
data (e.g. subscales) that were not 
pre-specified; 
-    One or more reported primary 
outcomes were not pre-specified 
(unless clear justification for their 
reporting is provided, such as an 
unexpected adverse effect); 
-    One or more outcomes of 
interest in the review are reported 
incompletely so that they cannot be 
entered in a meta-analysis; 
-    The study report fails to include 
results for a key outcome that would 
be expected to have been reported 
for such a study. 
Any of the following: 
-    The study protocol is available 
and all of the study’s pre-specified 
(primary and secondary) outcomes 
that are of interest in the review 
have been reported in the pre-
specified way; 
-    The study protocol is not 
available but it is clear that the 
published reports include all 
expected outcomes, including 
those that were pre-specified 
(convincing text of this nature may 
be uncommon). 
Insufficient information to 
permit judgement of ‘Low 
risk’ or ‘High risk’. It is 
likely that the majority of 
studies will fall into this 
category. 
Other 
sources of 
bias 
All 
State any important 
concerns about bias 
not addressed in the 
other domains in the 
tool. 
If particular 
questions/entries were 
pre-specified in the 
review’s protocol, 
responses should be 
provided for each 
question/entry. 
Bias due to 
problems not 
covered 
elsewhere in 
the table. 
There is at least one important risk 
of bias. For example, the study: 
-    Had a potential source of bias 
related to the specific study design 
used; or 
-    Has been claimed to have been 
fraudulent; or 
-    Had some other problem. 
The study appears to be free of 
other sources of bias. 
There may be a risk of 
bias, but there is either: 
-    Insufficient information 
to assess whether an 
important risk of bias 
exists; or 
-    Insufficient rationale or 
evidence that an identified 
problem will introduce 
bias. 
 
Abbreviation: RCT, randomized controlled trial 
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Supplementary Table 8. Characteristics of the studies 
 
   Studies reporting outcome that measures 
  All studies 
Attendance at the 
first or first two 
adult care visits 
Time between 
last pediatric 
and first adult 
visit 
Frequency 
of visits 
Clinic 
appointments 
attended 
    N=23 N=8 N=10 N=8 N=5 
Type of objective - % (n)      
  descriptive 17% (4) 1 1 2 1 
  identification of risk factors 52% (12) 4 4 3 2 
  evaluation of intervention 30% (7) 3 4 3 2 
Condition(s) of interest - % (n)      
  diabetes 48% (11) 2 6 6 2 
  congenital heart disease 17% (4) 1 1 1 - 
  sickle cell disease 13% (3) 2 2 - - 
  rheumatic disease 9% (2) 2 1 - 2 
  congenital adrenal hyperplasia 4% (1) 1 - - 1 
  cystic fibrosis 4% (1) - - 1 - 
  not specific 4% (1) - - - - 
Study design - % (n)      
  cross-sectional study 26% (6) 1 5 1 2 
   unique 22% (5) 1 5 - 2 
   repeated 4% (1) - - 1 - 
  cohort 70% (16) 7 5 7 3 
   retrospective 65% (15) 6 4 5 3 
   retrospective and prospective 4% (1) - - 1 - 
  randomized controlled trial 4% (1) 1 1 1 - 
Country - % (n)      
  USA 39% (9) 3 6 1 1 
  Canada 17% (4) 2 - 2 1 
  Europe 39% (9) 2 3 5 3 
  Australia 4% (1) 1 1 - - 
Number of participants      
  median 83 50 63 117 53 
  interquartile range 53 - 158 29 - 121 31 - 132 66 - 147 33 - 62 
Settings - % (n)      
  hospital pediatric care 35% (8) 4 4 2 2 
  hospital adult care 22% (5) 1 4 1 1 
  hospital pediatric and adult care 17% (4) 2 2 - 2 
  primary care and hospital adult care 4% (1) - - 1 - 
  non-medical settings 17% (4) 1 - 3 - 
  unclear 4% (1) - - 1 - 
No. of centers - % (n)      
  general population 13% (3) 1 - 1 - 
  single center 78% (18) 5 8 6 5 
  multicenter 9% (2) 2 2 1 - 
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Supplementary Table 8. (continued) 
 
   Studies reporting outcome that measures 
  All studies 
Attendance at 
the first or first 
two adult care 
visits 
Time 
between 
last 
pediatric 
and first 
adult visit 
Frequency 
of visits 
Clinic 
appointments 
attended 
    N=23 N=8 N=10 N=8 N=5 
Data collection      
 Retrospective chart review - % (n) 43% (10) 5 2 5 3 
 Administrative database - % (n) 30% (7) 3 2 1 4 
 Telephone interview with the patient - % (n) 26% (6) - 2 4 - 
 Non-web-based autoquestionnaire - % (n) 22% (5) - 3 2 - 
 Web-based autoquestionnaire - % (n) 13% (3) - 2 - - 
 Proxy interview (parents, etc.) - % (n) 13% (3) - 1 1 - 
 Interview with healthcare provider - % (n) 9% (2) 2 1 - 1 
 Face-to-face interview with the patient - % (n) 4% (1) - 1 - - 
 Unclear - % (n) 9% (2) 1 2 1 - 
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Supplementary Table 9. Description of the studies included: design, settings and study 
population 
 
Referenc
e 
Disease 
Study 
design 
Count
ry 
Settings and study population 
Settings 
No. of 
center
sa 
Age (years) Detailed population description 
Andemar
iam 2014 
Sickle 
cell 
disease 
Retrospect
ive cohort 
USA 
Hospital 
pediatric 
and adult 
care 
1 Range 16-24 
Patients aged 16 years or older 
attending a pediatric sickle cell 
disease center 
Busse 
2007 
Diabetes 
Retrospect
ive cohort 
Germ
any 
Primary 
care and 
hospital 
adult care 
1 
Mean 22.1; SD 
2.4; range 18-28 
Patients aged 18+ with diabetes, at 
least 6 months after their transfer to 
adult care 
Cadario 
2009 
Diabetes 
Cross-
sectional 
Italy 
Hospital 
pediatric 
and adult 
care 
1 Mean 19; SD 2.8 
Adolescents and young adults 
discharged from the pediatric diabetes 
service to the adult diabetic service of 
the same hospital (Maggiore della 
Carita` Hospital, Novara, Italy) from 
1994 to 2004 
Duguepe
roux 
2008 
Cystic 
fibrosis 
Repeated 
cross-
sectional 
Franc
e 
Hospital 
adult care 
1 
Median 21; 
range 18-35; 
mean 21.6 
Patients attending the Cochin adult 
cystic fibrosis center, transferred from 
one of the three pediatric cystic 
fibrosis centers in Paris between 
January 2001 and June 2004 
Garvey 
2012 & 
2013a 
Diabetes 
Cross-
sectional 
USA 
Hospital 
adult care 
1 
Range 22-30 ;  
mean 26.7 ; SD 
2.4 
Young adults (22-30 years old) with 
type 1 diabetes diagnosed before the 
age of 18, who had received pediatric 
diabetes care and were under the 
care of an adult diabetes specialist at 
the Joslin Diabetes Center 
Garvey 
2013 b 
Diabetes 
Retrospect
ive cohort 
USA 
Hospital 
pediatric 
care 
1 
Mean 26.6; SD 
3.0 
Young adults with type 1 diabetes, 
who had previously been followed at 
the pediatric diabetes clinic at Boston 
Children’s Hospital between June 
2000 and May 2010 and were at least 
15 years old at the last diabetes clinic 
visit 
Gleeson 
2013 
Congeni
tal 
adrenal 
hyperpla
sia 
Retrospect
ive cohort 
UK 
Hospital 
pediatric 
care 
1 
Median 25.5 
years (range 
18.4–47.8) 
Patients aged 16 years and older with 
congenital adrenal hyperplasia who 
had attended the adrenal clinic at the 
Royal Manchester Children’s Hospital 
between 1992 and 2009 
Goossen
s 2011 
Congeni
tal heart 
disease 
Retrospect
ive cohort 
Belgi
um 
Hospital 
pediatric 
care 
1 Range 21-25 
Patients with congenital heart disease 
examined and/or treated at a tertiary 
care center between 2000 and 2004, 
aged 21 years or older in 2009 and 
not cured in childhood 
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Supplementary Table 9. (continued) 
 
Referenc
e 
Disease 
Study 
design 
Count
ry 
Settings and study population 
Settings 
No. of 
center
sa 
Age (years) Detailed population description 
Hankins 
2012 
Sickle 
cell 
disease 
Retrospect
ive cohort 
USA 
Hospital 
pediatric 
care 
1 
Median 18.4 ; 
range 17-19 
Patients from a pediatric sickle cell 
center, aged 17 to 19 years, and 
sufficiently medically stable for 
transfer to another health care 
provider 
Hazel 
2010 
Rheuma
tic 
disease 
Retrospect
ive cohort 
Cana
da 
Hospital 
pediatric 
care 
1 Not available 
Patients with juvenile idiopathic 
arthritis who attended the MCH JIA 
clinic and who were subsequently 
transferred to the care of adult 
rheumatologists between 1992-2005 
Hersh 
2009 
Rheuma
tic 
disease 
Cross-
sectional 
USA 
Hospital 
adult care 
1 
Mean age at last 
pediatric 
rheumatology 
visit: 19.5; range 
17.4-22.0 
Patients ≤ 30 years old who 
transferred from the pediatric to adult 
rheumatology clinics at University of 
California San Francisco between 
1995 and 2005 (at least one 
scheduled adult rheumatology clinic 
visit) 
Kipps 
2002 
Diabetes 
Retrospect
ive cohort 
UK 
Not 
medical 
settings 
Gener
al 
popula
tion 
Mean 22.1; 
range 18.2-28.7 
Patients aged 18 years or older with a 
Type 1 diabetes diagnosed at <16 
years of age between 1985 and 1995 
Johnston 
2006 
Diabetes 
Retrospect
ive cohort 
UK 
Hospital 
pediatric 
and adult 
care 
1 Range 14-24 
All type 1 diabetic patients who 
transferred from pediatric to adult 
diabetic clinic services between 1 
January 2000 and 31 December 2001 
at Royal Belfast Hospital for Sick 
Children, UK 
Norris 
2013 
Congeni
tal heart 
disease 
Retrospect
ive cohort 
USA 
Not 
medical 
settings 
1 
Mean 24.5; 
range 21.7-27.2 
Young adults (aged 21-28 years) with 
congenital heart disease of moderate 
or severe complexity and an index 
cardiology clinic visit at the cardiac 
center during adolescence in 2001 or 
2002 (at age 14-18 years) 
Oswald 
2013 
Not 
specified 
Retrospect
ive cohort 
USA 
Not 
medical 
settings 
Gener
al 
popula
tion 
Range 19-23 
Children and youths with special 
health care needs who participated in 
the 2001 National Survey of Children 
with Special Health Care Needs 
Pacaud 
2005 
Diabetes 
Retrospect
ive cohort 
Cana
da 
Not 
medical 
settings 
Gener
al 
popula
tion 
Mean 20.5; SD 
2.2 
All patients with diabetes who had 
been transferred from pediatric-care 
to adult-care services by the diabetes 
clinic of the Alberta Children’s 
Hospital from June 1992 to June 1997 
Reid 
2004 
Congeni
tal heart 
disease 
Retrospect
ive cohort 
Cana
da 
Hospital 
pediatric 
care 
1 Range 19-21 
Young adults (19-21) with complex 
congenital heart disease in Canada 
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Supplementary Table 9. (continued) 
 
Referenc
e 
Disease 
Study 
design 
Count
ry 
Settings and study population 
Settings 
No. of 
center
sa 
Age (years) Detailed population description 
Stanczyk 
2014 
Diabetes 
Retrospect
ive cohort 
Polan
d 
Hospital 
pediatric 
care 
1 
Mean 20.4; SD 
1.2 
Patients with type 1 diabetes, aged 18 
years or older, transferred from the 
regional outpatient diabetes clinic at 
the Upper Silesian Center of Child 
Health in Katowice, Poland (2003–
2007) 
Steinbec
k 2014 
Diabetes 
Randomiz
ed 
controlled 
trial 
Austr
alia 
Hospital 
pediatric 
and adult 
care 
2 Range 17.3-18.8 
Young people with type 1 diabetes, 
identified by their diabetes specialists 
as ready to leave the pediatric 
diabetes service and transfer to adult 
care. 
Van 
Walleghe
m 2008 
Diabetes 
Retrospect
ive and 
prospectiv
e cohort 
Cana
da 
Unclear 1 
18 years old for 
one cohort; 19-
25 for the other 
Young adults with type 1 diabetes 
who transferred from pediatric to adult 
care. Two cohorts of participants: 1) a 
younger group (aged 18 years, n=82) 
assisted by a navigator during the 
transition from pediatric care and 2) 
an older group (aged 19 –25 years) 
who were transferred to adult care 
without this initial support but were 
later enrolled in the program 
Vanelli 
2004 
Diabetes 
Cross-
sectional 
Italy 
Hospital 
adult care 
1 
Mean 26.5 ; SD 
2.6 ; range 21-
29 
Patients with type 1 diabetes 
transferred from the Pediatric 
Diabetes Center to the Adult Diabetes 
Clinic of the University Hospital of 
Parma 
Wojciech
owski 
2002 
Sickle 
cell 
disease 
Retrospect
ive cohort 
USA 
Hospital 
pediatric 
care 
3 
Mean 20.3 ; 
range 18-24 
Patients with sickle cell disease, aged 
18-24, who had transferred to adult 
care within the past 3 years were 
chosen from three acute-care 
academic hospitals involved in 
treating children with sickle cell 
disease, from a large Midwestern city 
Yeung 
2008 
Congeni
tal heart 
disease 
Cross-
sectional 
USA 
Hospital 
adult care 
1 Range 16-71 
Patients with moderate- or high-
complexity congenital heart disease 
diagnosed in childhood and seen at a 
regional adult congenital heart 
disease clinic from 2002 to 2005 
 
awhen a study was performed in a pediatric and an adult center working together, they were counted together as a single center (i.e., one care 
pathway) 
 
